Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Developments And Opportunities Across 2026–2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market In 2026 And 2030?
The market for messenger ribonucleic acid (mrna) synthesis raw materials has experienced consistent growth over recent years. This market is projected to expand from $3.03 billion in 2025 to $3.12 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 3.0%. Factors contributing to its historical growth include the escalating demand for vaccines, progress in molecular biology, increased research and development investments in synthetic biology, the emergence of infectious disease outbreaks, and the creation of efficient transcription enzymes.
The messenger ribonucleic acid (mrna) synthesis raw materials market size is anticipated to undergo consistent expansion in the coming years. It is predicted to escalate to $3.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.0%. The projected growth is attributable to the proliferation of mRNA-based therapeutics, the integration of automated mRNA synthesis platforms, an uptick in personalized medicine initiatives, the expansion of biotechnology manufacturing hubs, and breakthroughs in nucleotide modifications. Significant trends during this forecast period include the optimization of synthetic mRNA, the creation of high-purity raw materials, the implementation of scalable in-vitro transcription processes, the standardization of the supply chain for mRNA production, and stringent quality control coupled with regulatory compliance.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
What Key Drivers Are Fueling The Growth Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The increasing occurrence of cancer and persistent health conditions is anticipated to fuel the expansion of the mRNA synthesis raw materials market. Cancer is a medical condition characterized by the uncontrolled proliferation of abnormal cells, capable of invading adjacent tissues and potentially spreading to distant parts of the body through the bloodstream and lymphatic systems. Chronic illnesses are generally defined as health issues that endure for a minimum of a year, necessitate ongoing medical care, hinder daily functions, or a combination of these factors. Raw materials for mRNA synthesis find application in drug research, vaccine creation, and the production of RNA-based treatments, providing enhanced immunogenicity, greater efficacy, and quicker production times suitable for addressing cancer and chronic ailments. For example, data released by the American Cancer Society, a US-based non-profit, indicated that in January 2024, the United States is expected to record 2,001,140 new cancer diagnoses and 611,720 cancer fatalities in 2024, marking an increase from 1,958,310 cases and 609,820 deaths in 2023. Additionally, as reported by the British Heart Foundation, a UK-based charity, in September 2025, over 7.6 million individuals across the UK, comprising more than 4 million men and over 3.6 million women, are afflicted with cardiovascular disease. Forecasts suggest that this figure could increase by roughly 1 million by 2030 and around 2 million by 2040, due to an aging demographic and better survival rates. Consequently, the rising prevalence of cancer and chronic conditions acts as a significant impetus for the mRNA synthesis of raw materials.
How Is Segmentation Applied In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Segment Analysis?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
What Emerging Trends Are Seen In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Major companies in the messenger ribonucleic acid (mRNA) synthesis raw materials market are concentrating on forming strategic collaborations to bolster their technological capabilities, broaden their range of high-quality raw materials, and accelerate the development of next-generation mRNA therapeutics. Strategic collaborations denote formal partnerships established between biotechnology firms, enzyme developers, and providers of nucleic acid technology. These partnerships aim to collaboratively create advanced in vitro transcription (IVT) enzymes, modified nucleotides, capping analogs, and other crucial inputs that improve mRNA yield, purity, stability, and safety. For instance, in September 2024, TriLink Biotechnologies, a US-based biotechnology company, teamed up with Alphazyme LLC, a US-based custom molecular biology enzyme company, to introduce the CleanScribe RNA Polymerase. This next-generation IVT enzyme is capable of reducing double-stranded RNA formation by up to 85% during mRNA synthesis, thereby contributing to the creation of safer and more potent mRNA therapeutics.
Who Are The Companies Participating In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Environment?
Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Get The Full Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report:
Which Region Dominates The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market By Market Share?
North America was the largest region in the mRNA synthesis raw materials market in 2025. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Ribose Nucleic Acid Rna Based Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
